North America To Dominate Global Cancer Immunotherapy Market According to new research. – Medgadget (blog)
|
North America To Dominate Global Cancer Immunotherapy Market According to new research.
Medgadget (blog) “Global Cancer Immunotherapy Market Research Report forecast 2017-2021 “Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The Global Cancer Immunotherapy Market Research Report Forecast 2017-2021 is a valuable … |
OncLive |
Dr. Smith Discusses CAR T Cells in Multiple Myeloma
OncLive The target of CAR T-cell therapy in multiple myeloma seems to be anti–B-cell maturation antigen (BCMA), says Smith. The investigational BCMA CAR T-cell therapy bb2121 had an objective response rate of 78% in patients with relapsed/refractory disease, … |
OncLive |
Dr. Smith Discusses CAR T Cells in Multiple Myeloma
OncLive The target of CAR T-cell therapy in multiple myeloma seems to be anti–B-cell maturation antigen (BCMA), says Smith. The investigational BCMA CAR T-cell therapy bb2121 had an objective response rate of 78% in patients with relapsed/refractory disease, … |
Fortune |
The Patent Battle Over Revolutionary CRISPR Gene-Editing Tech Just Went Global
Fortune In December, the life sciences world witnessed a milestone in the intellectual rights battle for the groundbreaking CRISPR/Cas9 gene-editing technology in the U.S. Back then, the big winners were the Broad Institute of MIT and Harvard University and … Europe says University of California deserves broad patent for …Science Magazine Europe Turns the Tables in the CRISPR Patent BattleLabiotech.eu (blog) Charpentier, UC Berkeley, U. Vienna to Be Granted European CRISPR PatentGenetic Engineering & Biotechnology News STAT –BioPharma Dive –Life Sciences Intellectual Property Review (subscription) all 34 news articles » |
EurekAlert (press release) |
A molecular on/off switch for CRISPR
EurekAlert (press release) For many bacteria, one line of defense against viral infection is a sophisticated RNA-guided “immune system” called CRISPR-Cas. At the center of this system is a surveillance complex that recognizes viral DNA and triggers its destruction. However … |